Christoph HUBER

Prof. HUBER is co-founder of BioNTech, Emeritus Professor of Medicine at the Medical School of the Johannes Gutenberg University in Mainz (Germany), co-founder and Head of the Supervisory Board at the Cluster for Individualized Immune Intervention (CI-3) and board member of the International Association of Cancer Immunotherapy (CIMT), among other roles.

He has over 40 years of clinical and research experience in hematology, oncology, stem cell transplantation and tumor immunology.